Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Titan Pharmaceuticals, Inc. (TTNP) had Tangible Shareholders Equity of $1.88M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.56M |
|
-- |
|
-- |
|
$0.53M |
|
$-0.53M |
|
$-0.03M |
|
$-0.56M |
|
$-0.56M |
|
$-0.56M |
|
$-0.56M |
|
$-0.56M |
|
$-0.56M |
|
$-0.53M |
|
$-0.53M |
|
0.91M |
|
0.91M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$2.16M |
|
-- |
|
-- |
|
$2.16M |
|
$0.28M |
|
-- |
|
-- |
|
$0.28M |
|
$1.88M |
|
|
Tangible Shareholders Equity |
$1.88M |
$1.88M |
|
0.91M |
|
| Cash Flow Statement Financials | |
$-0.87M |
|
-- |
|
$-0.02M |
|
$2.83M |
|
$1.95M |
|
$-0.89M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.01% |
|
-29.99% |
|
-26.11% |
|
-29.99% |
|
$2.05 |
|
$-0.95 |
|
$-0.95 |
|